At ROVI, we have a diversified portfolio comprising around thirty of our own and licensed products.
Our portfolio has a defensive profile, since it has been practically unaffected by reference pricing
in Spain and no significant patents will expire until 2019.
Absorcol®
Active Substance
Ezetimibe
Therapeutic Area
Cardiovascular
License
License from MSD
Ameride®
Active Substance
Amiloride hydrochloride and hydrochlorothiazide
Therapeutic Area
Cardiovascular
License
ROVI propietary product
Bertanel®
Active Substance
Methotrexate
Therapeutic Area
Osteoarticular
License
License from Ebewe Pharma Gmbh Nfg. KG
BLUXAM®
Active Substance
Hexacetonido de triamcinolona.
Therapeutic Area
Osteoarticular
License
License from Riemser Pharma Gmbh
CALCIUM AND VITAMINE
D3 ROVI®
Active Substance
Calcium carbonate and cholecalciferol concentrate.
Therapeutic Area
Osteoarticular
License
ROVI propietary product
CORDIPLAST®
Active Substance
Nitroglicerina
Therapeutic Area
Cardiovascular
License
License from Merus Labs Luxco II S.à.R.L.
ESTRADERM®
Active Substance
Estradiol. Patches
Therapeutic Area
Gynaecology
License
Merus Labs Luxco II S.à.R.L
EXXIV®
Active Substance
Etoricoxib
Therapeutic Area
Osteoarticular and pain release
License
License from MSD
GLUFAN®
Active Substance
Glucosamine hydrochloride
Therapeutic Area
Osteoarticular
License
ROVI propietary product
Hibor®
Active Substance
Sodium bemiparin
Therapeutic Area
Thrombosis
License
ROVI propietary product
Hirobriz®
Breezhaler®
Active Substance
Indacaterol maleate
Therapeutic Area
Pneumology
License
License from Novartis Europharm Limited
NEPARVIS®
Active Substance
Sacubitril/valsartan
Therapeutic Area
Cardiovascular
License
License from Novartis Europharm Limited
Medicebran®
Active Substance
Methylphenidate hydrochloride with inmediate release
Therapeutic Area
Central nervous system
License
License from MEDICE
Access to the physician´s guide and supportive material for monitoring of therapy through this link
Medikinet®
Active Substance
Methyilphenidate hydrochloride with modified release
Therapeutic Area
Central nervous system
License
License from MEDICE
Access to the physician´s guide and supportive material for monitoring of therapy through this link
Mysimba®
Active Substance
Naltrexone hydrochloride and bupropion hydrochloride. Prolonged release.
Therapeutic Area
Endocrinology
License
License from OREXIGEN
Orvatez®
Active Substance
Ezetimibe and Atorvastatin
Therapeutic Area
Cardiovascular
License
License from MSD
Prinivil®
Active Substance
Lisinopril
Therapeutic Area
Cardiovascular
License
ROVI propietary product
Rhodogil®
Active Substance
Spiramycin and Metronidazole
Therapeutic Area
Antibacterial
License
ROVI propietary product
SALAGEN®
Active Substance
Pilocarpine hydrochloride
Therapeutic Area
Oncology
License
Merus Labs Luxco II S.à.R.L
SINTROM®
Active Substance
Acenocoumarol
Therapeutic Area
Cardiovascular
License
Merus Labs Luxco II S.à.R.L
Vytorin®
Active Substance
Ezetimibe and simvastatin
Therapeutic Area
Cardiovascular
License
License from MSD
Volutsa®
Active Substance
Solifenacin succinate and tamsulosin hydrochloride
Therapeutic Area
Urology
License
License from Astellas Pharma
Tryptizol®
Active Substance
Amitriptyline hydrochloride
Therapeutic Area
Central nervous system
License
ROVI propietary product
Ulunar®
Breezhaler®
Active Substance
Indacaterol maleate and
glycopyrronium bromide
Therapeutic Area
Pneumology
License
License from Novartis Europharm Limited
ENOXAPARIN ROVI®
Active Substance
Sodium enoxaparin
Therapeutic Area
Thrombosis
License
ROVI propietary product